Return to Skip Menu

Main Content

Bioscience and investor conference expands reach

BLACKSBURG, Va., April 9, 2012 – With expectations of more than 1,000 attendees from industry, government, academia, and the investment community, the Mid-Atlantic Bio Conference is poised for growth.  

New this year is the alliance of the North Carolina Biotechnology Center. They join the Virginia Biotechnology Association, the Tech Council of Maryland, and the Mid-Atlantic Venture Association as strategic partners for the Sept. 27 through 28 event in Bethesda, Md.

Bioscience industry leaders from North Carolina’s Research Triangle will be connecting with senior executives from more than 200 companies, 50 investment funds, and researchers from the mid-Atlantic region’s top academic institutions. Virginia Tech is a research university sponsor and Continuing and Professional Education is an organizer of the conference.

Central to biotech research and policy, the combined mid-Atlantic region represents one of the nation’s largest industry clusters in number of companies, size of workforce, funding, innovation, clinical trials, and commercial opportunities.

According to David Mott, general partner of New Enterprise Associates and former chief executive officer of MedImmune, “The 2012 Mid-Atlantic Bio is well positioned to provide key insights for investors as to the pulse of the industry — from policy to pipelines. This means more venture capitalists, more investment opportunities, more high value attendees from the private and public sectors, more media, and more clarity as to what’s going on in Washington. In other words, this is where business from Maryland to North Carolina will get done.”

This is the seventh offering of the conference, and the multiplier effect of North Carolina’s participation will be key to this year’s event. “This partnership represents a rare platform to bring together influential stakeholders for the benefit of our companies and the industry as a whole,” said Mark A. Herzog, executive director of the Virginia Biotechnology Association, on behalf of the Mid-Atlantic Bio coalition. “Having already offered world-class collaboration, best practices exchange, and networking opportunities in the past, North Carolina is the catalyst which will propel Mid-Atlantic Bio, its sponsors and attendees, into the national spotlight.”   

Visit the conference website for more information about the event.